Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Int J Gynaecol Obstet. 2012 Aug;118(2):112-6. doi: 10.1016/j.ijgo.2012.03.028. Epub 2012 May 16.
To investigate demographic, socioeconomic, lifestyle, and medical factors that might predispose women to cervical human papillomavirus (HPV) infection.
A cross-sectional population-based study was performed. Women aged 18-64 years who attended selected obstetrics and gynecology or sexually transmitted disease (STD) clinics in mainland Portugal between February 2008 and March 2009 were recruited, according to an age-stratified sampling strategy. Liquid-based cytology samples were analyzed centrally for HPV genotype and for cytologic features. Univariate and multivariate logistic regression analyses identified risk factors for HPV infection.
Among the 2326 women evaluated, the crude prevalence of HPV infection was 19.4%. Lifetime number of sexual partners was a strong predictor of HPV infection (odds ratio 5.44 for 5-10 partners versus 1 partner; P<0.001). Other risk factors were young age (particularly among women aged 20-24 years; P<0.001); country of birth other than mainland Portugal (P=0.002); education up to secondary school level (P=0.010); smoking history (≤ 10 years; P=0.004); and any STD in the past 12 months (P=0.052).
Data from the present study may aid identification of women at increased risk of HPV infection and target prevention strategies.
National Commission of Data Protection (CNPD) registration number 5346/2007; Sanofi Pasteur MSD study number HPV-E05.
研究可能使女性易感染宫颈人乳头瘤病毒(HPV)的人口统计学、社会经济学、生活方式和医学因素。
进行了一项横断面人群基础研究。根据分层抽样策略,于 2008 年 2 月至 2009 年 3 月间招募了在葡萄牙大陆选定的妇产科或性传播疾病(STD)诊所就诊的 18-64 岁的女性。采集液基细胞学样本进行 HPV 基因型和细胞学特征的中心分析。单变量和多变量逻辑回归分析确定了 HPV 感染的危险因素。
在评估的 2326 名女性中,HPV 感染的粗患病率为 19.4%。终生性伴侣数量是 HPV 感染的强烈预测因素(与 1 个性伴侣相比,5-10 个性伴侣的比值比为 5.44;P<0.001)。其他危险因素包括年轻(尤其是 20-24 岁的女性;P<0.001);出生国非葡萄牙大陆(P=0.002);受教育程度至中学(P=0.010);吸烟史(≤10 年;P=0.004);以及过去 12 个月中的任何 STD(P=0.052)。
本研究的数据可能有助于识别 HPV 感染风险增加的女性,并针对预防策略。
国家数据保护委员会(CNPD)注册号 5346/2007;赛诺菲巴斯德 MSD 研究编号 HPV-E05。